PepGen Inc. (PEPG)
3.78
-0.15
(-3.82%)
USD |
NASDAQ |
Nov 20, 16:00
3.79
+0.01
(+0.26%)
After-Hours: 20:00
PepGen Gross Profit (TTM) : -1.155M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.155M |
| June 30, 2026 | -1.294M |
| March 31, 2026 | -1.328M |
| December 31, 2025 | -1.397M |
| September 30, 2025 | -1.441M |
| June 30, 2025 | -1.481M |
| March 31, 2025 | -1.517M |
| December 31, 2024 | -1.505M |
| September 30, 2024 | -1.479M |
| June 30, 2024 | -1.449M |
| March 31, 2024 | -1.41M |
| December 31, 2023 | -1.184M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.975M |
| June 30, 2023 | -0.769M |
| March 31, 2023 | -0.577M |
| December 31, 2022 | -0.493M |
| September 30, 2022 | -0.396M |
| June 30, 2022 | -0.299M |
| March 31, 2022 | -0.197M |
| December 31, 2021 | -0.16M |
| September 30, 2021 | -0.139M |
| March 31, 2021 | -0.093M |
| December 31, 2020 | -0.056M |
| September 30, 2020 | -0.027M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Korsana Biosciences, Inc. | -0.033M |
| IRulya Therapeutics, Inc. | -0.131M |
| Q32 Bio, Inc. | 53.39M |
| Bridgebio Oncology Therapeutics, Inc. | -0.763M |
| Oncolytics Biotech, Inc. | -0.048M |